Su Zhen
Direttore/Membro del Consiglio presso KARYOPHARM THERAPEUTICS INC.
Profilo
Su Zhen is currently the Chief Executive Officer & Director at Marengo Therapeutics, Inc., an Independent Director at Karyopharm Therapeutics, Inc., and an Independent Director at CytomX Therapeutics, Inc. Previously, Dr. Zhen held the position of SVP & Global Head-Oncology Business at Merck KGaA from 2019 to 2021, and Chief Medical Officer at EMD Serono, Inc. from 2017 to 2019.
Dr. Zhen holds an MBA from the University of Toronto and a doctorate from Dresden University of Technology.
Posizioni attive di Su Zhen
Società | Posizione | Inizio |
---|---|---|
KARYOPHARM THERAPEUTICS INC. | Direttore/Membro del Consiglio | 31/08/2023 |
CYTOMX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 21/03/2024 |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Amministratore Delegato | 01/07/2021 |
Precedenti posizioni note di Su Zhen
Società | Posizione | Fine |
---|---|---|
MERCK KGAA | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Direttore Tecnico/Scientifico/R&S | 01/01/2019 |
Formazione di Su Zhen
Dresden University of Technology | Doctorate Degree |
University of Toronto | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
MERCK KGAA | Health Technology |
CYTOMX THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Borsa valori
- Insiders
- Su Zhen